SEPN
Septerna, Inc.NASDAQHealthcare$25.18+3.32%ClosedMarket Cap: $1.13B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.92
P/S
24.61
EV/EBITDA
-13.05
DCF Value
$-12.99
FCF Yield
9.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-148.6%
Net Margin
-106.4%
ROE
-12.6%
ROA
-8.2%
ROIC
-13.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $24.1M | 100.0% | $-16.0M | $-10.7M | $-0.24 | — |
| FY 2025 | $46.0M | 100.0% | $-80.8M | $-48.9M | $-1.10 | — |
| Q3 2025 | $21.5M | 100.0% | $2.6M | $8.2M | $0.18 | — |
| Q2 2025 | $119.0K | 100.0% | $-29.0M | $-24.8M | $-0.56 | — |
| Q1 2025 | $219.0K | 100.0% | $-25.9M | $-21.5M | $-0.49 | — |
| Q4 2024 | $212.0K | 100.0% | $-24.7M | $-20.7M | $-0.64 | — |
| FY 2024 | $1.1M | 100.0% | $-80.8M | $-71.8M | $-7.26 | — |
| Q3 2024 | $176.0K | 100.0% | $-22.6M | $-20.5M | $-0.49 | — |
| Q2 2024 | $370.0K | 100.0% | $-18.1M | $-16.4M | $-0.39 | — |
| Q1 2024 | $317.0K | 100.0% | $-15.5M | $-14.2M | $-0.34 | — |
| Q4 2023 | $118.0K | 100.0% | $34.3M | $34.9M | $2.05 | — |
| FY 2023 | $151.0K | 100.0% | $2.1M | $4.2M | $0.03 | — |